Evidence map›Paper›PMID 37853291›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2024

Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).

Lorenzo Nanetti, Mary Kearney, Sylvia Boesch, Lucie Stovickova, Juan Darío Ortigoza-Escobar, Alfons Macaya, David Gomez-Andres, Emmanuel Roze, Maria-Judit Molnar, Nicole I Wolf and 23 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. The importance of genetic counselling for turner syndrome transition.European child & adolescent psychiatry · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 17 institutions in 10 countries.

Lorenzo NanettiUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy.
Mary KearneyPatient Advocate at the European Reference Network Representing Individuals With Ataxia, and Neurology Research Fellow at the National Ataxia Centre, Tallaght University, Dublin, Ireland.
Sylvia BoeschCenter for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria.
Lucie StovickovaCentre of Hereditary Ataxias, Department of Pediatric Neurology, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
Juan Darío Ortigoza-EscobarPediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Alfons MacayaPediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain.
David Gomez-AndresPediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain.
Emmanuel RozeSorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France.
Maria-Judit MolnarInstitute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.
Nicole I WolfAmsterdam Leukodystrophy Center, Department of Child Neurology, Emma's Children's Hospital, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, The Netherlands.
Alejandra DarlingPediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Gessica VascoResearch Unit of Neurorehabilitation, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy.
Enrico BertiniUnit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy.
Elisabetta IndelicatoCenter for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria.
David NeubauerUMCL, Children's Hospital Ljubljana and University of Ljubljana, Ljubljana, Slovenia.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics University of Tübingen, Tübingen, Germany.
Judit C SagiInstitute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.
Federica R DantiDepartment of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Deborah SivalDepartment of Paediatric Neurology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Ginevra ZanniUnit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy.
Anneli KolkTartu University Hospital Children's Clinic, Department of Pediatrics and Neurology, Tartu, Estonia.
Odile Boespflug-TanguyAPHP, Université Paris Cité, INSERM UMR1141, Hôpital Robert Debré, Service de Neuropédiatrie, Centre de Reference LEUKOFRANCE, Paris, France.
Ludger ScholsDepartment of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany.
Bart van de WarrenburgDonders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Marie VidailhetSorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France.
Michèl A WillemsenDonders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Annemieke I BuizerDepartment of Rehabilitation Medicine, Emma Children's Hospital, Amsterdam, Vrije Universiteit, Amsterdam, Amsterdam Movement Science, Rehabilitation and Development, Amsterdam, The Netherlands.
Enrico OrzesOsservatorio Malattie Rare - Rarelab S.R.L., Rome, Italy.
Sophie RippCentre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
Carola ReinhardCentre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
Isabella MoroniDepartment of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Caterina MariottiUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy. caterina.mariotti@istituto-besta.it.ORCID http://orcid.org/0000-0003-2405-3564
ERN-RND Working Group for Management of Transition
Fondazione IRCCS Istituto Neurologico Carlo Besta · ITBambino Gesù Children's Hospital · ITUniversity of Tübingen · DECentre National de la Recherche Scientifique · FRHospital Sant Joan de Déu Barcelona · ESRadboud University Nijmegen · NLSemmelweis University · HUUniversitat Autònoma de Barcelona · ESUniversity Medical Center Groningen · NLAmsterdam Neuroscience · NLEmma Kinderziekenhuis · NLGerman Center for Neurodegenerative Diseases · DEInserm · FRTallaght University Hospital · IETartu University Hospital · EEUniversity Hospital in Motol · CZUniversity of Ljubljana · SI

Funding

European Union ERN-RND Framework Partnership Agreement 2022-23
6 · The paper itself

Abstract

backgroundTransition from child-centered to adult-centered healthcare is a gradual process that addresses the medical, psychological, and educational needs of young people in the management of their autonomy in making decisions about their health and their future clinical assistance. This transfer is challenging across all chronic diseases but can be particularly arduous in rare neurological conditions.

aimTo describe the current practice on the transition process for young patients in centers participating in the European Reference Network for Rare Neurological Diseases (ERN-RND).

methodsMembers of the ERN-RND working group developed a questionnaire considering child-to-adult transition issues and procedures in current clinical practice. The questionnaire included 20 questions and was sent to members of the health care providers (HCPs) participating in the network.

resultsTwenty ERN-RND members (75% adult neurologists; 25% pediatricians; 5% nurses or study coordinators) responded to the survey, representing 10 European countries. Transition usually occurs between 16 and 18 years of age, but 55% of pediatric HCPs continue to care for their patients until they reach 40 years of age or older. In 5/20 ERN-RND centers, a standardized procedure managing transition is currently adopted, whereas in the remaining centers, the transition from youth to adult service is usually assisted by pediatricians as part of their clinical practice.

conclusionsThis survey demonstrated significant variations in clinical practice between different centers within the ERN-RND network. It provided valuable data on existing transition programs and highlighted key challenges in managing transitions for patients with rare neurological disorders.

Indexed as

Delivery of Health CareNervous System DiseasesAdolescentAdultChildEuropeHumansRare DiseasesSurveys and QuestionnairesChild-to-adult transitionClinical practiceEuropean Reference Networks (ERNs)Rare neurological diseasesTransition careYoung healthcare management

Identifiers

PMID37853291
OpenAlexW4387733350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.